We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

170 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2017 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $667K | Put options by funds: $414K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 46

15% more capital invested

Capital invested by funds: $514M → $592M (+$78M)

3% more funds holding

Funds holding: 165 → 170 (+5)

Holders
170
Holders Change
+5
Holders Change %
+3.03%
% of All Funds
4.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
58
Reduced
46
Closed
20
Calls
$667K
Puts
$414K
Net Calls
+$253K
Net Calls Change
+$299K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$6.87M
2
Millennium Management
Millennium Management
New York
+$4.83M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$4.82M
4
IECM
Intrinsic Edge Capital Management
Illinois
+$4.22M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.46M

Top Sellers

Rank Fund Capital Flow
1
DIA
Dean Investment Associates
Ohio
-$5.71M
2
PP
Prudential plc
United Kingdom
-$3.62M
3
BTW
Boston Trust Walden
Massachusetts
-$3.26M
4
JP Morgan Chase
JP Morgan Chase
New York
-$3.23M
5
DCM
Dean Capital Management
Kansas
-$3.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
26
Fifth Third Bancorp
Ohio
$3.42M +$1.3K +90 +0%
GAM
27
Gotham Asset Management
New York
$3.37M -$289K -20,054 -9%
Bank of America
28
Bank of America
North Carolina
$3.33M +$1.29M +89,433 +73%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$3.32M -$368K -25,561 -11%
CIS
30
Connors Investor Services
Pennsylvania
$3.23M -$197K -13,648 -6%
GF
31
Gabelli Funds
New York
$3.21M – – –
Invesco
32
Invesco
Georgia
$3M +$178K +12,354 +7%
PPA
33
Parametric Portfolio Associates
Washington
$2.98M +$416K +28,888 +18%
MIP
34
Mondrian Investment Partners
United Kingdom
$2.8M +$401K +27,848 +19%
NFA
35
Nationwide Fund Advisors
Ohio
$2.79M +$1.89K +131 +0.1%
Two Sigma Investments
36
Two Sigma Investments
New York
$2.78M -$1.26M -87,251 -33%
GI
37
GAMCO Investors
Connecticut
$2.76M – – –
QCG
38
Quadrant Capital Group
Ohio
$2.49M +$3.21K +223 +0.1%
RA
39
Royce & Associates
New York
$2.49M – – –
TA
40
Teton Advisors
New York
$2.44M – – –
Barrow, Hanley, Mewhinney & Strauss
41
Barrow, Hanley, Mewhinney & Strauss
Texas
$2.37M +$2.05M +142,536 +1,874%
Deutsche Bank
42
Deutsche Bank
Germany
$2.35M +$269K +18,650 +14%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$2.25M -$26.3K -1,827 -1%
New York State Teachers Retirement System (NYSTRS)
44
New York State Teachers Retirement System (NYSTRS)
New York
$2.21M -$44.7K -3,100 -2%
Goldman Sachs
45
Goldman Sachs
New York
$2.15M +$56.4K +3,915 +3%
CS
46
Credit Suisse
Switzerland
$2.12M -$284K -19,729 -13%
OAM
47
Oxford Asset Management
United Kingdom
$2.09M +$794K +55,110 +71%
HEC
48
Hudson Executive Capital
New York
$1.94M +$1.78M +123,300 New
TCIM
49
TIAA CREF Investment Management
New York
$1.81M +$18.6K +1,294 +1%
SFM
50
Systematic Financial Management
New Jersey
$1.79M -$366K -25,410 -18%
1
2
3 4 5

VIVO Hedge Fund Activity: Q2 2017 in Review

170 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2017, worth a combined $592M — up 15% from $514M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new VIVO positions and 20 closed out — a net gain of 7 holders — while 58 added to existing stakes and 46 trimmed.

The largest buyer was UBS Group, adding an estimated $6.87M. The largest seller was Dean Investment Associates, exiting entirely with an estimated $5.71M sold.

  • 170 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2017, up from 165 in Q1 2017.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q2 2017, up 15% quarter-over-quarter.
  • 27 funds opened new Meridian Bioscience Inc positions in Q2 2017 and 20 closed out, a net change of +7 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2017 was UBS Group, an estimated $6.87M added.
  • The largest Meridian Bioscience Inc seller in Q2 2017 was Dean Investment Associates, an estimated $5.71M sold.

Based on aggregated 13F filings for Q2 2017.